The Global Fish Skin Disease Market is estimated to be valued at US$ 1.4 Bn in 2023 and is expected to exhibit a CAGR of 9.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Fish skin disease refers to various infections and inflammatory conditions that affect the skin of fish. Common types of fish skin diseases include bacterial infections, fungal infections, parasitic infections and other non-infectious conditions. Fish farmers rely on topical therapeutics to treat skin infections and maintain healthy fish stocks.
Market key trends:
One of the key trends fueling the growth of the fish skin disease market is rising adoption of telehealth services. With advancements in digital healthcare technologies, major players are offering telemedicine and e-consultation services for fish farms. This allows farmers to consult fish disease experts virtually and get diagnostic and treatment recommendations without physically visiting clinics. Telehealth is helping improve accessibility of fish healthcare, especially in remote areas. It is also reducing treatment costs by enabling efficient disease management. This growing popularity of telehealth is expected to drive significant growth in the fish skin disease market over the forecast period.
Segment Analysis
The global fish skin disease market is dominated by the aquaculture segment. The increasing demand for seafood consumption has led to mass culture of fish species in aquaculture farms, enhancing the risk of fungal, bacterial and parasitic infections including fish skin diseases. Poor water quality maintenance and overcrowding of fish in farms are major reasons for frequent outbreaks of infections. With rising commercialization of fish farming, the aquaculture segment is expected to continue dominating the market over the forecast period.
Key Takeaways
The Global Fish Skin Disease Market is expected to witness high growth, exhibiting CAGR of 9.8% over the forecast period, due to increasing demand for seafood consumption globally.
Regional analysis: North America is currently the largest market for fish skin disease treatment, owing to strong presence of fish farming industry and developed healthcare infrastructure. Asia Pacific is expected to witness fastest growth due to rising investment in aquaculture farms and increasing initiative by governments to curb losses due to infections.
Market size: The global fish skin disease market size was valued at US$ 1.4 Billion in 2022.
Key players: Key players operating in the fish skin disease market are GSK Plc., AbbVie Inc., Sonnet BioTherapeutics, Krystal Biotech, LEO Pharma, GALDERMA, GLENMARK PHARMACEUTICALS LTD., Mayne Pharma Group Limited, Ortho Dermatologics, Cellegy Pharmaceuticals, Patagonia Pharmaceuticals, LLC, Crown Laboratories, Inc. These players are focused on developing novel treatment formulations and vaccines to prevent outbreaks in aquaculture farms.